AAAnton A. Avramenko

Anton A. Avramenko

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anton A. Avramenko has a total of 71 co-authors. Here are the top co-authors by number of shared publications:

  • Nikolay A. Svechkov

    Samara State Medical University

    4 shared publications
  • S. E. Shorokhov

    Samara State Medical University; V. P. Polyakov Samara Regional Clinical Cardiology Dispensary

    3 shared publications
  • Sergey M. Khokhlunov

    Samara State Medical University

    3 shared publications
  • Aleksandr Yu. Miller

    Межрегиональная общественная организация детских кардиохирургов «Общество специалистов по врожденным порокам сердца», Санкт-Петербург, Российская Федерация; Федеральное государственное бюджетное учреждение «Федеральный центр сердечно-сосудистой хирургии» Министерства здравоохранения Российской Федерации, Красноярск, Российская Федерация

    2 shared publications
  • Aleksey N. Arkhipov

    Meshalkin National Medical Research Center

    2 shared publications
  • Andrei A. Svobodov

    Федеральное государственное бюджетное учреждение «Национальный медицинский исследовательский центр сердечно-сосудистой хирургии имени А.Н. Бакулева» Министерства здравоохранения Российской Федерации, Москва

    2 shared publications

Latest Publications

  • Open Access

    Results of using fresh decellularized allografts for pulmonary valve replacement

    by N. A. Svechkov, S. A. Grishin, S. E. Shorokhov, A. A. Avramenko, S. M. Khokhlunov, Н. А. Свечков, С. А. Гришин, С. Е. Шорохов, А. А. Авраменко, С. М. Хохлунов

    The OBJECTIVE was to perform a comparative analysis of the outcomes of using different types of fresh decellularized allografts in the pulmonary position.METHODS AND MATERIALS. The study was conducted at the Department of Surgery with the course of Cardiovascular Surgery of the Institute of Continuing Professional Education, Samara State Medical University, based at the V. P. Polyakov Samara Regional Clinical Cardiology Dispensary. This was a single-center retrospective comparative cohort study based on the experience of pulmonary valve replacement with fresh decellularized allografts in patients with congenital heart disease from 2008 to 2022. A total of 134 patients (72 males and 62 females) who met the inclusion criteria underwent 185 interventions on the pulmonary valve. Freedom from reintervention was assessed using the Kaplan–Meier method; intergroup differences were evaluated with the Mantel – Cox log-rank test. Statistical significance was set at p≤0.05.RESULTS. In the early postoperative period, all groups demonstrated a low rate of complications and 30-day mortality. During follow-up, redo valve replacement due to allograft dysfunction was required in 22 cases (11.9 %). Pulmonary allografts showed the best durability: the median freedom from reintervention was 156 months, compared with 95 months for aortic allografts and 10 months for venous allografts; the differences between the groups were statistically significant (p<0.001). Venous allografts were characterized by early calcification and a high need for reoperation during the first year of follow-up. In our cohort, older age at the time of surgery and larger conduit diameter were associated with longer allograft durability.CONCLUSION. Fresh decellularized pulmonary allografts demonstrated the best freedom from reintervention compared with aortic and, particularly, venous allografts and may be considered a preferred option for pulmonary valve replacement. Venous allografts in the pulmonary position were characterized by early dysfunction and a high need for reinterventions, which restricts their use as long-term valved conduits.

  • Open Access

    Surgical Management of Congenital Heart Disease in the Russian Federation for 2025.

    by Ilya A. Soynov, Alexey I. Kim, Ruben Rudolfovich Movsesyan, Pavel Viktorovich Teplov, Aleksandr Yu. Miller, Yuriy Yu. Kulyabin, Aleksey N. Arkhipov, Anton A. Avramenko, Kirill V. Gorbatikov, Artem V. Gorbatykh, et al.

    Introduction: Systematic monitoring of outcomes in patients with congenital heart disease (CHD) is essential for improving the quality of care. Since 2024, a national multicenter digital registry designed to consolidate data from the country’s leading expert centers has been undergoing pilot implementation in the Russian Federation. Objective: To assess surgical volumes, the distribution of diagnoses, and in-hospital mortality associated with treatment for CHD and cardiac arrhythmias in the Russian Federation using 2025 registry data. Methods: We retrospectively analyzed de-identified data from 15,634 patients treated at 32 cardiac surgery centers in the Russian Federation that provide care to patients younger than 18 years with CHD. Procedural complexity was assessed using the RACHS II risk-stratification system. Outcomes were analyzed by age group, including neonates with low birth weight. Results: Overall in-hospital mortality was 1.30% (vs. 1.42% in 2024). Open surgical procedures accounted for 48.3% of interventions, transcatheter procedures for 37.6%, and procedures for cardiac arrhythmias for 12.8%. The most common CHD diagnoses were atrial septal defect (23.96%), patent ductus arteriosus (22.42%), and ventricular septal defect (15.47%).The highest mortality was observed among neonates undergoing surgerywith cardiopulmonary bypass (9.5%). Conclusion: The 2025 data confirm a sustained decline in overall mortalityand support the effectiveness of implementing national standards. Further improvement in neonatal surgery for complex defects remains a priority. Implementation of a unified system enabling patient-level identification and personalized assessment of treatment effectiveness is also essential. Received 8 July 2026. Revised 12 July 2026. Accepted 20 August 2026. Funding The study did not have sponsorship. Conflict of InterestThe authors declare no conflict of interest. Contribution of the authorsConception and study design: I.A. Soynov, R.R. Movsesyan, P.V. Teplov, A.A. Svobodov, E.V. Krivoshchekov, E.S. Tarasyuk Data collection and analysis: I.A. Soynov, A.Yu. Miller, Yu.Yu. Kulyabin, A.N. Arkhipov, A.A. Avramenko, K.V. Gorbatikov, A.V. Gorbatykh, K.A. Nalimov, S.A. Kovalev, A.A. Svobodov, A.A. Shikhranov, M.V. Plotnikov, O.A. Egunov, V.A. Belov, I.V. Gladyshev, K.B. Kazantsev, O.Yu. Kornoukhov, A.V. Nokhrin, D.Yu. Petrushenko, E.S. Efanov, I.K. Khalivopulo, D.V. Ryabtsev, Yu.A. Sobolev, V.N. Medvedev, R.Yu. Gavrilov, N.I. Pavlov Statistical analysis: I.A. Soynov, P.V. Teplov, K.A. Nalimov, M.A. Abramyan, S.A. Kovalev Drafting the article: I.A. Soynov, A.Yu. Miller, Yu.Yu. Kulyabin, A.A. Avramenko, K.V. Gorbatikov, A.V. Gorbatykh, K.A. Nalimov, A.V. Kauk, E.V. Krivoshchekov, E.N. Amansakhatova Critical revision of the article: A.I. Kim, R.R. Movsesyan, M.A. Abramyan, E.V. Krivoshchekov, E.S. Tarasyuk Final approval of the version to be published: all authors

  • Fontan Failure in Adult Patients: From Physiology to Solutions

    by Egor A. Karev, Oksana F. Stovpyuk, Daria V. Alekseeva, Diana S. Malishevskaya, Lev M. Malishevsky, Anton A. Avramenko

    The adult population with congenital heart defects of varying complexity is growing rapidly. This includes a significant number of patients over the age of 18 who underwent surgery in early childhood to correct conotruncal anomalies and septal defects. While patients with a functional single ventricle palliated with the Fontan procedure are still relatively rare in developing countries, the expertise gained from managing these patients in expert centers in Europe and the United States of America, as well as the success of pediatric cardiac surgery, has drawn increasing attention to this subject. In this review article, we aim to discuss the unique pathophysiology of Fontan circulation and clinical issues in the management of adult patients, with a particular focus on identifying specific predictors of heart failure decompensation and potential complications in this population.

  • Open Access

    Surgical management of congenital heart diseases in the Russian Federation: national registry data for 2024

    by Ilya A. Soynov, Алексей Иванович Ким, Ruben R. Movsesyan Movsesyan, Павел Викторович Теплов, Александр Юрьевич Миллер, Yuriy Yu. Kulyabin, Анон Алексеевич Авраменко, Кирилл Виктрович Горбатиков, Artem V. Gorbatykh, Константин Александрович Налимов, et al.

    Introduction. Congenital heart diseases (CHDs) remain a leading cause ofinfant mortality and disability, underlining their high medico-social significance.In the context of rapid technological advancements, evolving demographicindicators, and improvements in prenatal diagnostics, systemic monitoring of treatment outcomes at the national level has become critically important. The national registry facilitates an objective assessment of current cardiac surgical care effectiveness nationwide, helps identify regional trends, and determines priority areas for the implementation of modern hybrid and endovascular protocols. Objective. To evaluate the current status and outcomes of surgical treatment for congenital heart diseases (CHD) in the Russian Federation based on the 2024 national multicenter registry data. Methods. A retrospective analysis of 14,640 surgical procedures performed across 31 cardiac surgery centers was conducted. The RACHS II scoring system was utilized for risk stratification. The study assessed hospital mortality rates, pathology distribution, and the efficacy of various surgical strategies. Results. The overall hospital mortality rate was 1.42 %. Endovascular procedures accounted for a significant proportion (38.4 %) of interventions. In the interventional arrhythmia segment (n = 1,342), zero mortality was achieved. The highest risk remains in the neonatal group (6.6 % mortality). Analysis of palliative care revealed the superiority of the hybrid approach: ductal stenting in duct-dependent patients showed half the mortality rate (4.95 %) compared to the surgical systemic-to-pulmonary artery shunt (9.74 %). Complex reconstructions (Norwood procedure) remain a high-risk area. Conclusion. The national pediatric cardiac surgery registry demonstrates high efficacy and safety for routine interventions. There is a distinct trend towards replacing open surgery with endovascular techniques. Centralization of care for critical CHDs in expert centers and the adoption of hybrid technologies are key factors for further improving outcomes.


  • Staged repair of pulmonary atresia with intact ventricular septum

    by A.A. Avramenko, S.A. Grishin, N.A. Svechkov, S.E. Shorokhov, S.M. Khokhlunov

    OBJECTIVE To analyze the results of treatment in patients with pulmonary atresia and intact interventricular septum (PA IVS) depending on morphological features. MATERIAL AND METHODS The study included 18 patients treated in 2005—2022. Seven (39%) patients underwent biventricular correction (group 1). They had a median tricuspid valve Z-score 0.85, tripartite right ventricular (RV) and no RV-dependent coronary blood flow. Eleven (61%) patients underwent univentricular correction (group 2). They had a median tricuspid valve Z-score –2.50, unipartite or bipartite RV and RV-dependent coronary blood flow in 3 cases. Mean follow-up period was 20.5 and 57.0 months, respectively. RESULTS There were no significant between-group differences in survival (p=0.731). Functional class of heart failure in long-term period was similar. CONCLUSION Criteria for PA IVS correction accompanied by favorable early and mid-term results for biventricular repair: tricuspid valve Z-score ≥–2.5, tripartite RV, no RV-dependent coronary blood flow; for univentricular correction: tricuspid valve Z-score <–2.5, unipartite or bipartite RV, RV-dependent coronary blood flow.

  • Open Access

    Reconstruction of the pulmonary vascular bed at the stages of hemodynamic correction in patients with functionally single ventricle

    by A. A. Avramenko, N. A. Svechkov, S. M. Khokhlunov

    The OBJECTIVE was to study the prevalence and nature of congenital and acquired anatomical features of the pulmonary vascular bed in patients with single ventricle and to evaluate their impact on staged hemodynamic correction.METHODS AND MATERIALS. The study was a retrospective cohort study based on the study of the experience of surgical treatment of patients with a single ventricle from 2005 to 2022. 208 patients, 95 females and 113 males met the inclusion criteria. Depending on the type of the first stage of correction, all patients were divided into three groups: 1 – patients after the Norwood operation (n=84), 2 – patients after the isolated systemic-to-pulmonary shunts (n=74), 3 – patients after pulmonary artery band or those who did not need the first stage of surgical treatment (n=50).RESULTS. From all patients who survived the Stage-I (158 patients), 47 (30 %) patients underwent 72 reconstructive interventions on the pulmonary arteries: 8 % – before Stage-II, 46 % – at Stage-II, 17 % – between stages II and III, 11 % – at Stage-III and 18 % – after Stage-III. When comparing freedom from stenosis of the pulmonary arteries, statistically significant differences were found between groups of patients (p=0.005), with the least freedom from stenosis in group 1 (after the Norwood operation) and the greatest freedom from stenosis in group 3 (after pulmonary artery band or without first stage of correction).CONCLUSIONS. Patients with a functionally single ventricle are at risk of developing pulmonary artery stenosis throughout the entire period of staged hemodynamic correction and after its completion. The identified narrowing needs immediate correction, since a long-term existing narrowing can lead to hypoplasia of the pulmonary vascular bed and become an obstacle to the timely Fontan completion. More extensive use of tomographic imaging techniques is recommended in order to fully assess the degree of narrowing.


  • Open Access

    Retrospective analysis of outcomes in patients with myocardial infarction in late admission to PCI center

    by S. A. Vorontsova, T. V. Pavlova, A. A. Avramenko, S. M. Khokhlunov

    Aim. This study aims to determine the impact of invasive treatment strategy on long-term outcomes in patients with ST-segment elevation myocardial infarction (STEMI) in late admission to PCI center (12-48 hours from the symptom onset) in comparison with conservative management.Material and methods. The study population included 154 people with STEMI, admitted to V. P. Polyakov Samara Regional Clinical Cardiology Dispensary during 12-48 hours after onset of myocardial ischemia symptoms, for the period of inclusion (2013-2017). The mean age of the patients was 57,2±9,2 years old. The study evaluated two time periods: intrahospital and long-term (during 4 years from the index hospitalization). The primary end-point: cardiovascular death. The secondary combined end-point included: myocardial infarction recurrence, life-threatening rhythm disturbances, acute bleeding, heart failure NYHA III-IV functional class. The patients were divided into two groups depending on initially chosen management strategy: invasive (I) (n=113; 73,4%) or conservative (II) treatment (n=41; 26,6%).Results. Comparing frequency of occurrence of cardiovascular death depending on chosen treatment tactics, we found that the probability of lethal outcome from cardiovascular causes in conservatively treated patients increased by 20,64 times (95% confidence interval (CI): 1,04-408,61), p=0,018 during intrahospital period of the study. The analysis performed using the Kaplan-Meier method showed the medians of the time of lethal outcome occurrence: in conservative group — 76,5 months (95% CI: 67,6-85 months), in invasive group — 92,1 months (95% CI: 88,9-95,3 months), p=0,014.Conclusion. This study presented the results of our own retrospective study which confirms that revascularization in late-presenting patients with STEMI (12-48 hours from the symptom onset) results in improving the outcomes in both intrahospital and long-term periods.

  • False Aneurysm of the Proximal Sano Shunt in a Patient With Hypoplastic Left Heart Syndrome After Bidirectional Superior Cavopulmonary Connection

    by S A Grishin, M D Svechkov, S E Shorokhov, A A Avramenko

    The case describes the surgical treatment of a patient with a false aneurysm of the proximal anastomosis of the Sano shunt in a patient with hypoplastic left heart syndrome midterm after bidirectional cavo-pulmonary anastomosis. The diagnostic algorithm included a physical examination, echocardiography, and multispiral computed tomography. Surgical treatment included closure of the right ventricular defect and removal of blood clots from the cavity of the false aneurysm.


  • Systemic veins in patients with functionally single ventricle: anatomic features and their influence to staged hemodynamic palliation

    by Samara V.P. Polyakov Samara Regional Clinical Cardiac Hospital, A.A. Avramenko, Samara State Medical University of the Ministry of Healthcare of the Russian Federation, N.A. Svechkov, T.V. Kislukhin, S.E. Shorokhov

    Системные вены у пациентов с функционально единственным желудочком сердца: анатомические особенности и их влияние на этапную гемодинамическую